Quit Genius Stock

quitgenius.comHealthcare / Digital HealthFounded: 2017Funding to Date: $63.21MM

Quit Genius is the provider of a digital clinic for treating nicotine, alcohol and opioid addictions.

Register To Buy and Sell Shares

For more details on financing and valuation for Quit Genius, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Quit Genius’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Quit Genius.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Quit Genius’ Stock

Can you buy Quit Genius stock?
Quit Genius is not publicly traded on NYSE or NASDAQ in the U.S. To buy Quit Genius stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Quit Genius stock?
Yes, you can sell stock of a private company like Quit Genius. Forge can help you sell your Quit Genius stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Quit Genius’ stock price?
Quit Genius is a privately held company and therefore does not have a public stock price. However, you may access Quit Genius’ private market stock price with Forge Data.
What is Quit Genius’ stock ticker symbol?
Quit Genius does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: Dec 9, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.